-Express News Service Union Human Resource Development Minister Kapil Sibal on Tuesday said that a national-level task force would be set up to frame guidelines to protect the interest of severely disabled children. Disability activists had last week raised objections to a clause in the Right to Education Act that gives the option of home-based schooling for children with severe disabilities. In a meeting with activists on Tuesday, Sibal assured that all...

At least 75 complaints of corruption and misconduct against serving judges of the Supreme Court and high courts were forwarded in the last one year for “appropriate action” by the government to the Chief Justice of India (CJI) and chief justices of concerned high courts.   The justice department of the law ministry, which forwards these complaints, has told HT that it “is unaware of any action taken on these complaints” by...

The implementation of Right to Education Act may have got a shot in the arm with the recent Supreme Court ruling upholding the 25% reservation in unaided private schools for children from lower income group families but inAndhra Pradesh (and possibly other states in the country), the Act might soon figure among the many well-intentioned government schemes that do not impact, leave alone benefit, its target group. At best, the...

NOVARTIS has long been suing the Government of India to eliminate or weaken Section 3(d) of the Patents (Amendment) Act, 2005, which established strict standards of patentability in order to prevent the ever-greening of patent monopolies on medicines. Although Novartis lost in 2007 its initial efforts to have Section 3(d) declared unconstitutional and violative of international norms for national patent regimes, it has persisted in appealing and re-appealing the denial...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...